DiaMedica Therapeutics (DMAC) Earnings Date, Estimates & Call Transcripts $7.05 +0.20 (+2.92%) Closing price 10/15/2025 04:00 PM EasternExtended Trading$6.97 -0.08 (-1.12%) As of 10/15/2025 07:55 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock DiaMedica Therapeutics Earnings Summary DiaMedica Therapeutics announced Q2 2025 earnings on August 12, 2025, reporting an EPS of -$0.18, which met the consensus estimate of -$0.18. With a trailing EPS of -$0.69, DiaMedica Therapeutics' earnings are expected to decrease next year, from ($0.59) to ($0.80) per share. Upcoming Q3 Earnings DateNov. 12After Market ClosesEstimatedConsensus EPS (Aug. 12) -$0.18 Actual EPS (Aug. 12) -$0.18 Q2 2025 Earnings ResourcesQ2 2025 Earnings ReportConference Call Transcript & Audio Press Release (8-K) Quarterly Report (10-Q)DMAC Upcoming EarningsDiaMedica Therapeutics' Q3 2025 earnings is scheduled for Wednesday, November 12, 2025, with a conference call scheduled on Thursday, November 13, 2025 at 8:00 AM ET. Check back for transcripts, audio, and key financial metrics as they become available.Powered by Get DiaMedica Therapeutics Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on DiaMedica Therapeutics and other key companies, straight to your inbox. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Charts & View Estimated and Actual Earnings DataDMAC Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter. DiaMedica Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20251-$0.18-$0.18-$0.18Q2 20251-$0.18-$0.18-$0.18Q3 20251-$0.18-$0.18-$0.18Q4 20251-$0.18-$0.18-$0.18 DiaMedica Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 11/12/2025(Estimated)--------8/12/2025Q2 2025-$0.18-$0.18--$0.18--5/13/2025Q1 2025-$0.18-$0.18--$0.18--3/17/2025Q4 2024-$0.17-$0.18 -$0.01-$0.18--8/7/2024Q2 2024-$0.16-$0.13+$0.03-$0.13--5/8/2024Q1 2024-$0.16-$0.14+$0.02-$0.14--3/20/2024--$0.14-$0.14--$0.14--11/13/2023Q3 2023-$0.14-$0.12+$0.02-$0.12-- DiaMedica Therapeutics Earnings - Frequently Asked Questions When is DiaMedica Therapeutics' earnings date? DiaMedica Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, November 12th, 2025 based off last year's report dates. Learn more on DMAC's earnings history. Did DiaMedica Therapeutics beat their earnings estimates last quarter? In the previous quarter, DiaMedica Therapeutics (NASDAQ:DMAC) reported ($0.18) earnings per share (EPS) to hit the analysts' consensus estimate of ($0.18). Learn more on analysts' earnings estimate vs. DMAC's actual earnings. How can I listen to DiaMedica Therapeutics' earnings conference call? The conference call for DiaMedica Therapeutics' latest earnings report can be listened to online. Listen to Conference Call How can I read DiaMedica Therapeutics' conference call transcript? The conference call transcript for DiaMedica Therapeutics' latest earnings report can be read online. Read Transcript How much profit does DiaMedica Therapeutics generate each year? DiaMedica Therapeutics (NASDAQ:DMAC) has a recorded net income of -$24.44 million. DMAC has generated -$0.69 earnings per share over the last four quarters. What is DiaMedica Therapeutics' EPS forecast for next year? DiaMedica Therapeutics' earnings are expected to decrease from ($0.59) per share to ($0.80) per share in the next year. More Earnings Resources from MarketBeat Related Companies Avadel Pharmaceuticals Earnings Date Janux Therapeutics Earnings Date Arcus Biosciences Earnings Date Stoke Therapeutics Earnings Date LENZ Therapeutics Earnings Date Syndax Pharmaceuticals Earnings Date Sionna Therapeutics Earnings Date Xeris Biopharma Earnings Date Taysha Gene Therapies Earnings Date Zymeworks Earnings Date Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Why Congress Is Buying Intuitive Surgical Ahead of Earnings3 Reasons to Buy Sprouts Farmers Market Ahead of EarningsTesla Earnings Loom: Bulls Eye $600, Bears Warn of $300Spotify Could Surge Higher—Here’s the Hidden Earnings SignalBerkshire-Backed Lennar Slides After Weak Q3 EarningsWall Street Eyes +30% Upside in Synopsys After Huge Earnings FallRH Stock Slides After Mixed Earnings and Tariff Concerns This page (NASDAQ:DMAC) was last updated on 10/16/2025 by MarketBeat.com Staff From Our PartnersURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredAI's Next Magnificent SevenThe original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredGenerate up to $5,000/month with 10X less money?The secret to retiring without a million-dollar nest egg. I'm talking about generating enough monthly inco...Investors Alley | SponsoredBuy this stock before Tesla’s November 6 announcementThe End of Tesla? "Hold onto your Tesla stock." That's the message insiders at Tesla have been giving staff...Altimetry | SponsoredREVEALED: Something Big Happening Behind White House DoorsWhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredTrump Devises the Death of the IRS ☠️Trump has just signed an executive order creating America's first-ever National Investment Fund — a game-chang...Angel Publishing | SponsoredGold to $27,533?This week, U.S. gold reserves hit an unprecedented $1 TRILLION in value... And it's sparking urgent chatter...Stansberry Research | SponsoredShots officially fired…Elon Musk just declared war on the wireless giants with a $17 billion spectrum deal that gives SpaceX the righ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding DiaMedica Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share DiaMedica Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
